Sanctuary Advisors LLC Has $9.51 Million Holdings in Colgate-Palmolive (NYSE:CL)

Sanctuary Advisors LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 6.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 104,633 shares of the company's stock after selling 6,638 shares during the quarter. Sanctuary Advisors LLC's holdings in Colgate-Palmolive were worth $9,510,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CL. State Street Corp raised its stake in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after buying an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Colgate-Palmolive by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after buying an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after buying an additional 557,492 shares in the last quarter. Barclays PLC raised its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares in the last quarter. Finally, FMR LLC raised its stake in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after buying an additional 2,674,807 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.9 %

Shares of NYSE:CL traded up $1.69 during mid-day trading on Friday, reaching $89.56. The stock had a trading volume of 4,747,229 shares, compared to its average volume of 4,884,892. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market cap of $72.68 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. The firm has a 50 day simple moving average of $89.02 and a two-hundred day simple moving average of $95.99. Colgate-Palmolive has a twelve month low of $84.45 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the company posted $0.87 EPS. On average, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.23%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 56.82%.

Wall Street Analysts Forecast Growth

CL has been the topic of several analyst reports. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a report on Friday, January 17th. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a report on Monday, January 6th. UBS Group lowered their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Finally, TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.